It was approved by the FDA in 2021 for weight management in obese or overweight adults with at least one weight-related issue (e.g., T2DM, high blood pressure, or high cholesterol) in combination with diet and exercise
You struggle with daily medication adherence: If you've historically had difficulty with daily medications of any kind, a weekly injection removes that barrier
Summary: GLP-1 receptor agonists can produce clinically significant weight loss without structured exercise, though combining medication with physical activity optimises outcomes and preserves muscle mass
Both disproportionality analyses confirmed this heightened risk: ROR analysis showed a statistically significant association (ROR = 1.81, 95% CI 1.622.03), while BCPNN yielded an information component of IC = 0.85 (IC025 = 0.69), both indicating substantially greater renal impairment risks in this older population treated with the combination therapy
The mechanism is well-understood
Research on semaglutide is ongoing, and more studies are needed to fully understand its impact on urinary health